 REDWOOD CITY, Calif., Nov. 17, 2020 PRNewswire -- Nevro Corp. NYSE: NVRO, a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced today that both data abstracts for Painful Diabetic Neuropathy PDN and... 